Search by Drug Name or NDC
NDC 67457-0530-35 LEUCOVORIN CALCIUM 350 mg/17.5mL Details
LEUCOVORIN CALCIUM 350 mg/17.5mL
LEUCOVORIN CALCIUM is a INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Institutional LLC. The primary component is LEUCOVORIN CALCIUM.
MedlinePlus Drug Summary
Leucovorin is used to prevent harmful effects of methotrexate (Rheumatrex, Trexall; cancer chemotherapy medication) when methotrexate is used to treat certain types of cancer. Leucovorin is also used to treat people who have accidentally received an overdose of methotrexate or similar medications. Leucovorin is in a class of medications called folic acid analogs. It works by protecting healthy cells from the effects of methotrexate or similar medications while allowing methotrexate to enter and kill cancer cells.
Related Packages: 67457-0530-35Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Leucovorin
Product Information
| NDC | 67457-0530 |
|---|---|
| Product ID | 67457-530_2890b03c-dbef-4db8-8b07-c042d7765677 |
| Associated GPIs | 21755040102160 |
| GCN Sequence Number | 044534 |
| GCN Sequence Number Description | leucovorin calcium VIAL 350 MG INJECTION |
| HIC3 | V1I |
| HIC3 Description | CHEMOTHERAPY RESCUE/ANTIDOTE AGENTS |
| GCN | 87553 |
| HICL Sequence Number | 001063 |
| HICL Sequence Number Description | LEUCOVORIN CALCIUM |
| Brand/Generic | Generic |
| Proprietary Name | LEUCOVORIN CALCIUM |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | LEUCOVORIN CALCIUM |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 350 |
| Active Ingredient Units | mg/17.5mL |
| Substance Name | LEUCOVORIN CALCIUM |
| Labeler Name | Mylan Institutional LLC |
| Pharmaceutical Class | Folate Analog [EPC], Folic Acid [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203800 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 67457-0530-35 (67457053035)
| NDC Package Code | 67457-530-35 |
|---|---|
| Billing NDC | 67457053035 |
| Package | 1 VIAL, SINGLE-DOSE in 1 CARTON (67457-530-35) / 17.5 mL in 1 VIAL, SINGLE-DOSE |
| Marketing Start Date | 2019-01-02 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |